About BiosunPharmed

History

Biosun Pharmed Co. is a subsidiary of Barakat Pharmaceutical Holding Co. registered on October 20, 2012. The company's fields of activity include research, development and production of biosimilar products, vaccines, monoclonal antibodies and peptide medications. This company operates in three centers: the main factory is located in the Barakat pharmaceutical science and technology town, located in the Alborz province, the biotechnology and peptide site called “Biosun Darou” in Yaftabad, as well as the headquarters of the company in Tehran.

Honors

  • Since the last two decades, the Ministry of Health and Medical Education has sought to replace DPT vaccine with DTP-HepB-Hib vaccine (Pentavalent) in the Preventable Diseases Plan. Biosun Pharmed Co. is proud to have helped the country's health system since 2012 with contributions to the national economy in the field of medicine and vaccine.
    In this regard, Biosun Pharmed Co. has introduced the national DTP-HepB-Hib vaccine project (Pentavalent) to the country's vaccination program. Biosun Pharmed is the first and only manufacturer of Pentavalent vaccine in Iran. The company's products have been used in the national vaccination program since 2014;
  • Production and registration of the eptifibatide pharmaceutical ingredients (raw material) for the first time in Iran
  • Obtaining a certificate of Good Manufacturing Practice (GMP) for the production of pharmaceutical Ingredients;
  • Acting as a sponsor for the Neurological and MS Congress in 2014.